. Author manuscript; available in PMC: 2015 Dec 28.

Published in final edited form as: J Neurovirol. 2008 Nov;14(6):550–557. doi: 10.1080/13550280802372313

Table 2.

Characteristics of study subjects’ antiretroviral (ARV) drug regimens pre- and post-TI.

	Pre-TI	Post-TI
Number of ARVs in regimen (median [range])	3 [3–5]	3 [3–7]
% containing PIs	73	36
% containing NRTIS^*	100	100
% containing NNRTIs	27	73
% reporting at least 95% adherence to HAART^†	82	91

NRTIs include NARTIs.

^†

Adherence information not available for one subject.

PI = protease inhibitors; NRTIs = nucleoside reverse transcriptase inhibitors; NNRTIs = non-nucleoside reverse transcriptase inhibitors; NARTIs = nucleotide analogue reverse transcriptase inhibitors.